Overall rank by patents
#27,930
Across all tracked assignees
USPTO PatentsView assignee record - 9 granted patents across 12 technology areas, active 2016–2020. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: C30B (SINGLE-CRYSTAL GROWTH ; UNIDIRECTIONAL SOLIDIFICATION OF EUTECTIC MATERIAL OR UNIDIRECTIONAL DEMIXING OF EUTECTOID MATERIAL; REFINING BY ZONE-MELTING OF MATERIAL ; PRODUCTION OF A HOMOGENEOUS POLYCRYS).
The verdict
1366 holds 9 US patents across 12 technology areas, rank #27,930 of 50,000 tracked assignees.
1366 Technologies Inc. has been granted 9 US utility patents between 2016 and 2020, placing 1366 Technologies Inc. at rank #27,930 across all assignees tracked by PlainPatent. This portfolio spans 12 distinct Cooperative Patent Classification (CPC) subclasses, averaging 19.3 claims per patent with primary concentration in C30B (SINGLE-CRYSTAL GROWTH ; UNIDIRECTIONAL SOLIDIFICATION OF EUTECTIC MATERIAL OR UNIDIRECTIONAL DEMIXING OF EUTECTOID MATERIAL; REFINING BY ZONE-MELTING OF MATERIAL ; PRODUCTION OF A HOMOGENEOUS POLYCRYS). As a US Corporation, 1366 Technologies Inc. is one of the more focused assignees in the PatentsView dataset. By volume, 1366 sits between Vida Therapeutics Inc. (10 patents, rank #27,926) and 3-V Biosciences, Inc. (9 patents, rank #27,934) - the closest US assignees by grant volume. The composite Innovation Score of 31.8/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 3 grants, compared with 6 in the 2015–2019 window, a -50% shift in five-year velocity. A cooling filing rate may reflect portfolio consolidation, shifting priorities, or reduced R&D throughput. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. 1366 Technologies Inc.'s 19.3 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while concentration in 12 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark 1366 Technologies Inc. against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
viDA Therapeutics Inc.
10 patents
1004335 ONTARIO INC.
9 patents
1010210 B.C. LTD.
9 patents
1311854 Ontario Limited
9 patents
1929803 Ontario Corp.
9 patents
1A Smart Start LLC
9 patents
2KDirect, Inc.
9 patents
3-V Biosciences, Inc.
9 patents
1366 TECHNOLOGIES INC.
9 patents
What this shows 1366 holds 9 patents at rank #27,930, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #27,930 in granted patent volume.
Other assignees with the most granted patents in 1366's primary technology class.
1366's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
32 Top 61% higher than 39% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2016 | 2 | 22.2% |
| 2017 | 2 | 22.2% |
| 2018 | 1 | 11.1% |
| 2019 | 1 | 11.1% |
| 2020 | 3 | 33.3% |
Top 12 of 12 technology areas
Overall rank by patents
#27,930
Across all tracked assignees
31.8 out of 100
How to use this portfolio
1366's 9 grants land it in the top 61% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.